Compugen Leads Consortium to Model Cancer Related Kinase Pathway
European Commission to Fund SIMAP Consortium
10-Mar-2006 -
Compugen Ltd. announced that it is leading a consortium for the development of a platform to simulate the MAP-kinase pathway, a signaling pathway related to cancer which is already targeted by a number of cancer therapies and diagnostic tests.
The Simulation Modeling of the MAP-kinase Pathway ...
biology
clinical trials
consultancy
+4